BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $13.04 million. The enterprise value is $23.74 million.

Market Cap	13.04M
Enterprise Value	23.74M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BiomX has 17.90 million shares outstanding. The number of shares has increased by 76.68% in one year.

Shares Outstanding	17.90M
Shares Change (YoY)	+76.68%
Shares Change (QoQ)	+72.53%
Owned by Insiders (%)	3.76%
Owned by Institutions (%)	8.80%
Float	13.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.80, with a Debt / Equity ratio of 0.36.

Current Ratio	4.80
Quick Ratio	4.42
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.46

Financial Efficiency

Return on equity (ROE) is -121.29% and return on invested capital (ROIC) is -50.69%.

Return on Equity (ROE)	-121.29%
Return on Assets (ROA)	-32.66%
Return on Capital (ROIC)	-50.69%
Revenue Per Employee	n/a
Profits Per Employee	-$369,761
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $19,000 in taxes.

Income Tax	19,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.39% in the last 52 weeks. The beta is 1.32, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	-76.39%
50-Day Moving Average	1.01
200-Day Moving Average	2.52
Relative Strength Index (RSI)	23.14
Average Volume (20 Days)	33,459

Short Selling Information

The latest short interest is 26,481, so 0.15% of the outstanding shares have been sold short.

Short Interest	26,481
Short Previous Month	21,055
Short % of Shares Out	0.15%
Short % of Float	0.20%
Short Ratio (days to cover)	0.73

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.70M
Pretax Income	-37.11M
Net Income	-26.25M
EBITDA	-27.71M
EBIT	-28.70M
Earnings Per Share (EPS)	-$4.14

Full Income Statement

Balance Sheet

The company has $31.61 million in cash and $9.90 million in debt, giving a net cash position of $21.72 million or $1.21 per share.

Cash & Cash Equivalents	31.61M
Total Debt	9.90M
Net Cash	21.72M
Net Cash Per Share	$1.21
Equity (Book Value)	27.43M
Book Value Per Share	-0.72
Working Capital	27.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.76 million and capital expenditures -$48,000, giving a free cash flow of -$34.81 million.

Operating Cash Flow	-34.76M
Capital Expenditures	-48,000
Free Cash Flow	-34.81M
FCF Per Share	-$1.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-76.68%
Shareholder Yield	-76.68%
Earnings Yield	-201.40%
FCF Yield	-267.01%

Analyst Forecast

The average price target for BiomX is $22.50, which is 2,988.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.50
Price Target Difference	2,988.54%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-43.41%

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1